Key points are not available for this paper at this time.
Essas descobertas definem uma base genética para o benefício do bloqueio de CTLA-4 no melanoma e fornecem uma justificativa para examinar exomas de pacientes para os quais agentes anti-CTLA-4 estão sendo considerados. (Financiado pelo Frederick Adler Fund e outros.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Alexandra Snyder
Vladimir Makarov
Taha Merghoub
New England Journal of Medicine
Cornell University
Columbia University
University of California, Los Angeles
Building similarity graph...
Analyzing shared references across papers
Loading...
Snyder et al. (Qui,) estudaram essa questão.
www.synapsesocial.com/papers/69d9d8fc84371aa676a3c136 — DOI: https://doi.org/10.1056/nejmoa1406498
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: